SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019028
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:36
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20230930x10q.htm   iXBRL 10-Q 1870571
2 EX-31.1 krbp-20230930xex31d1.htm EX-31.1 23262
3 EX-31.2 krbp-20230930xex31d2.htm EX-31.2 23970
4 EX-32.1 krbp-20230930xex32d1.htm EX-32.1 7755
5 EX-32.2 krbp-20230930xex32d2.htm EX-32.2 7885
  Complete submission text file 0001558370-23-019028.txt   7375759

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20230930.xsd EX-101.SCH 46446
7 EX-101.CAL krbp-20230930_cal.xml EX-101.CAL 40624
8 EX-101.DEF krbp-20230930_def.xml EX-101.DEF 179203
9 EX-101.LAB krbp-20230930_lab.xml EX-101.LAB 408011
10 EX-101.PRE krbp-20230930_pre.xml EX-101.PRE 315344
63 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20230930x10q_htm.xml XML 1400243
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 231406457
SIC: 2836 Biological Products, (No Diagnostic Substances)